Biotricity, Inc. (BTCY) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Biotricity, Inc. (BTCY) Bundle
Whether you’re an investor or analyst, this (BTCY) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Biotricity, Inc., you can easily adjust forecasts and observe the results in real-time.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.4 | 3.4 | 7.7 | 9.6 | 12.1 | 19.6 | 32.0 | 52.0 | 84.7 | 137.9 |
Revenue Growth, % | 0 | 138.75 | 126.02 | 26 | 25.15 | 62.79 | 62.79 | 62.79 | 62.79 | 62.79 |
EBITDA | -10.9 | -13.4 | -18.0 | -15.4 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
EBITDA, % | -771 | -394.47 | -235.55 | -159.81 | -73.75 | -94.75 | -94.75 | -94.75 | -94.75 | -94.75 |
Depreciation | .1 | .3 | .1 | .3 | .0 | 1.0 | 1.6 | 2.6 | 4.3 | 7.0 |
Depreciation, % | 10.49 | 10.26 | 0.89329 | 3.59 | 0.04934784 | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
EBIT | -11.1 | -13.7 | -18.1 | -15.8 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
EBIT, % | -781.49 | -404.72 | -236.45 | -163.4 | -73.8 | -94.76 | -94.76 | -94.76 | -94.76 | -94.76 |
Total Cash | .9 | 2.2 | 12.1 | .6 | .8 | 9.6 | 15.6 | 25.4 | 41.4 | 67.4 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .5 | 1.5 | 2.0 | 1.2 | 1.8 | 5.2 | 8.5 | 13.9 | 22.6 | 36.7 |
Account Receivables, % | 34.29 | 44.93 | 26.23 | 12.7 | 14.96 | 26.62 | 26.62 | 26.62 | 26.62 | 26.62 |
Inventories | .1 | .3 | .8 | 2.3 | 1.9 | 2.6 | 4.2 | 6.8 | 11.0 | 17.9 |
Inventories, % | 6.05 | 8.05 | 11.02 | 24.25 | 15.58 | 12.99 | 12.99 | 12.99 | 12.99 | 12.99 |
Accounts Payable | 1.1 | 1.0 | 1.2 | 3.4 | 5.2 | 7.9 | 12.9 | 21.0 | 34.2 | 55.7 |
Accounts Payable, % | 77.17 | 30.77 | 15.16 | 35.64 | 43.29 | 40.4 | 40.4 | 40.4 | 40.4 | 40.4 |
Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | -.1 | -.1 |
Capital Expenditure, % | 0 | 0 | -0.3891 | 0 | 0 | -0.07781949 | -0.07781949 | -0.07781949 | -0.07781949 | -0.07781949 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -11.1 | -13.7 | -18.1 | -15.8 | -8.9 | -18.6 | -30.3 | -49.3 | -80.3 | -130.7 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -10.4 | -14.6 | -19.0 | -13.8 | -7.2 | -19.0 | -28.6 | -46.6 | -75.8 | -123.4 |
WACC, % | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 | 20.7 |
PV UFCF | ||||||||||
SUM PV UFCF | -145.7 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -126 | |||||||||
Terminal Value | -673 | |||||||||
Present Terminal Value | -263 | |||||||||
Enterprise Value | -408 | |||||||||
Net Debt | 23 | |||||||||
Equity Value | -432 | |||||||||
Diluted Shares Outstanding, MM | 9 | |||||||||
Equity Value Per Share | -47.99 |
What You Will Get
- Real BTCY Financial Data: Pre-filled with Biotricity’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Biotricity’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Data: Biotricity’s historical financial statements and detailed projections.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Monitor Biotricity’s intrinsic value calculations instantly.
- Visual Data Representation: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Biotricity, Inc. (BTCY) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the updated results, including Biotricity, Inc.'s (BTCY) intrinsic value.
- Step 5: Use the outputs to make informed investment decisions or create reports.
Why Choose Biotricity, Inc. (BTCY) Calculator?
- Save Time: Skip the hassle of building a financial model from the ground up – it's ready for immediate use.
- Enhance Accuracy: Dependable financial data and formulas minimize valuation errors.
- Fully Customizable: Adjust the model to align with your specific assumptions and forecasts.
- Easy to Understand: Intuitive charts and outputs simplify result analysis.
- Endorsed by Professionals: Crafted for experts who prioritize precision and user-friendliness.
Who Should Use Biotricity, Inc. (BTCY)?
- Healthcare Professionals: Understand the latest innovations in biometric monitoring and patient care.
- Researchers: Utilize Biotricity's technologies for studies in medical diagnostics and treatment efficacy.
- Investors: Evaluate market trends and performance metrics related to Biotricity, Inc. (BTCY) for informed investment decisions.
- Medical Device Analysts: Enhance your analysis with comprehensive data on Biotricity’s product offerings and market position.
- Entrepreneurs: Discover how Biotricity, Inc. (BTCY) is shaping the future of healthcare technology and explore potential business opportunities.
What the Template Contains
- Preloaded BTCY Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.